MX2009008540A - Inhibidores de virus de hepatitis c macrociclicos sustituidos con pirimidina. - Google Patents
Inhibidores de virus de hepatitis c macrociclicos sustituidos con pirimidina.Info
- Publication number
- MX2009008540A MX2009008540A MX2009008540A MX2009008540A MX2009008540A MX 2009008540 A MX2009008540 A MX 2009008540A MX 2009008540 A MX2009008540 A MX 2009008540A MX 2009008540 A MX2009008540 A MX 2009008540A MX 2009008540 A MX2009008540 A MX 2009008540A
- Authority
- MX
- Mexico
- Prior art keywords
- hcv inhibitors
- pyrimidine substituted
- compounds
- substituted macrocyclic
- macrocyclic hcv
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Compuestos de la fórmula I: (ver fórmula (I)) incluyendo un estereoisómero del mismo, ó un N-óxido, una sal de adición farmacéuticamente aceptable, o un solvato de adición farmacéuticamente aceptable del mismo; útiles como inhibidores de HCV; procedimientos para preparar estos compuestos así como composiciones farmacéuticas que comprenden estos compuestos como ingrediente activo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07102005 | 2007-02-08 | ||
PCT/EP2008/051553 WO2008095999A1 (en) | 2007-02-08 | 2008-02-08 | Pyrimidine substituted macrocyclic hcv inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009008540A true MX2009008540A (es) | 2009-08-18 |
Family
ID=39301259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009008540A MX2009008540A (es) | 2007-02-08 | 2008-02-08 | Inhibidores de virus de hepatitis c macrociclicos sustituidos con pirimidina. |
Country Status (13)
Country | Link |
---|---|
US (1) | US8937080B2 (es) |
EP (1) | EP2118091B1 (es) |
JP (1) | JP5554569B2 (es) |
KR (1) | KR20090110314A (es) |
CN (2) | CN105254637A (es) |
AU (1) | AU2008212758B2 (es) |
BR (1) | BRPI0807087A2 (es) |
CA (1) | CA2677697A1 (es) |
ES (1) | ES2541660T3 (es) |
HK (1) | HK1220455A1 (es) |
MX (1) | MX2009008540A (es) |
RU (1) | RU2481340C2 (es) |
WO (1) | WO2008095999A1 (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY140680A (en) | 2002-05-20 | 2010-01-15 | Bristol Myers Squibb Co | Hepatitis c virus inhibitors |
US8207341B2 (en) | 2008-09-04 | 2012-06-26 | Bristol-Myers Squibb Company | Process or synthesizing substituted isoquinolines |
UY32099A (es) * | 2008-09-11 | 2010-04-30 | Enanta Pharm Inc | Inhibidores macrocíclicos de serina proteasas de hepatitis c |
TW201040181A (en) | 2009-04-08 | 2010-11-16 | Idenix Pharmaceuticals Inc | Macrocyclic serine protease inhibitors |
WO2011017389A1 (en) | 2009-08-05 | 2011-02-10 | Idenix Pharmaceuticals, Inc. | Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv |
HUE035337T2 (en) * | 2010-05-20 | 2018-05-02 | Array Biopharma Inc | Macrocyclic compounds as TRK kinase inhibitors |
CN103534256B (zh) | 2010-12-30 | 2016-08-10 | 益安药业 | 大环丙型肝炎丝氨酸蛋白酶抑制剂 |
JP2014506255A (ja) | 2010-12-30 | 2014-03-13 | エナンタ ファーマシューティカルズ インコーポレイテッド | フェナントリジン大環状c型肝炎セリンプロテアーゼ阻害剤 |
US9353100B2 (en) | 2011-02-10 | 2016-05-31 | Idenix Pharmaceuticals Llc | Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections |
US8957203B2 (en) | 2011-05-05 | 2015-02-17 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
US8691757B2 (en) | 2011-06-15 | 2014-04-08 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
CN103387509B (zh) * | 2012-05-11 | 2016-06-08 | 重庆博腾制药科技股份有限公司 | 一种hcv蛋白酶抑制剂中间体的制备方法 |
ES2613766T3 (es) | 2012-10-19 | 2017-05-25 | Bristol-Myers Squibb Company | Derivados de carbamato de hexadecahidrociclopropa(e)pirrolo(1,2-a)(1,4)diazaciclopentadecinilo sustituidos con 9-metilo como inhibidores de la proteasa no estructural 3 (NS3) para el tratamiento de infecciones del virus de la hepatitis C |
US9598433B2 (en) | 2012-11-02 | 2017-03-21 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US9643999B2 (en) | 2012-11-02 | 2017-05-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
EP2914598B1 (en) | 2012-11-02 | 2017-10-18 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
US9409943B2 (en) | 2012-11-05 | 2016-08-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
JP6342922B2 (ja) | 2013-03-07 | 2018-06-13 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | C型肝炎ウイルス阻害剤 |
EP3089757A1 (en) | 2014-01-03 | 2016-11-09 | AbbVie Inc. | Solid antiviral dosage forms |
JP7286317B2 (ja) | 2015-10-27 | 2023-06-05 | エフ. ホフマン-ラ ロシュ アーゲー | Acinetobacter baumanniiに対するペプチド大環状分子 |
SI3380467T1 (sl) | 2015-11-27 | 2021-08-31 | Janssen Sciences Ireland Unlimited Company | Heterociklični indoli za uporabo v okužbi z virusom gripe |
KR20180100375A (ko) * | 2016-01-20 | 2018-09-10 | 얀센 사이언시즈 아일랜드 유씨 | 인플루엔자 바이러스 감염에서 사용하기 위한 아릴 치환 피리미딘 |
EP3388444A1 (en) | 2017-04-10 | 2018-10-17 | F. Hoffmann-La Roche AG | Anti-bacterial peptide macrocycles and use thereof |
US11505573B2 (en) | 2018-03-28 | 2022-11-22 | Hoffmann-La Roche Inc. | Peptide macrocycles against Acinetobacter baumannii |
US11819532B2 (en) | 2018-04-23 | 2023-11-21 | Hoffmann-La Roche Inc. | Peptide macrocycles against Acinetobacter baumannii |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2174992T3 (es) | 1992-12-29 | 2002-11-16 | Abbott Lab | Productos intermediarios para la obtencion de compuestos inhibidores de proteasas retrovirales. |
IL110752A (en) | 1993-09-13 | 2000-07-26 | Abbott Lab | Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor |
US5559158A (en) | 1993-10-01 | 1996-09-24 | Abbott Laboratories | Pharmaceutical composition |
IL111991A (en) | 1994-01-28 | 2000-07-26 | Abbott Lab | Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent |
US6037157A (en) | 1995-06-29 | 2000-03-14 | Abbott Laboratories | Method for improving pharmacokinetics |
CZ298749B6 (cs) | 1996-10-18 | 2008-01-16 | Vertex Pharmaceuticals Incorporated | Inhibitory serinových proteáz a farmaceutické prostředky s jejich obsahem |
GB9623908D0 (en) | 1996-11-18 | 1997-01-08 | Hoffmann La Roche | Amino acid derivatives |
JP4452401B2 (ja) | 1997-08-11 | 2010-04-21 | ベーリンガー インゲルハイム (カナダ) リミテッド | C型肝炎ウイルス阻害ペプチドアナログ |
NZ514540A (en) | 1999-03-19 | 2003-11-28 | Vertex Pharma | Phenyl derivative useful as inhibitors of IMPDH enzyme |
UA74546C2 (en) * | 1999-04-06 | 2006-01-16 | Boehringer Ingelheim Ca Ltd | Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition |
SV2003000617A (es) | 2000-08-31 | 2003-01-13 | Lilly Co Eli | Inhibidores de la proteasa peptidomimetica ref. x-14912m |
MY140680A (en) * | 2002-05-20 | 2010-01-15 | Bristol Myers Squibb Co | Hepatitis c virus inhibitors |
JP5248783B2 (ja) * | 2004-01-30 | 2013-07-31 | メディヴィル・アクチエボラーグ | Hcvns−3セリンプロテアーゼインヒビター |
MY139923A (en) * | 2005-07-29 | 2009-11-30 | Tibotec Pharm Ltd | Macrocylic inhibitors of hepatitis c virus |
JO2768B1 (en) * | 2005-07-29 | 2014-03-15 | تيبوتيك فارماسيوتيكالز ليمتد | Large cyclic inhibitors of hepatitis C virus |
PE20070343A1 (es) * | 2005-07-29 | 2007-05-12 | Medivir Ab | Inhibidores macrociclicos del virus de la hepatitis c |
US7741281B2 (en) * | 2005-11-03 | 2010-06-22 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
-
2008
- 2008-02-08 CA CA002677697A patent/CA2677697A1/en not_active Abandoned
- 2008-02-08 BR BRPI0807087-3A2A patent/BRPI0807087A2/pt not_active IP Right Cessation
- 2008-02-08 RU RU2009133472/04A patent/RU2481340C2/ru not_active IP Right Cessation
- 2008-02-08 JP JP2009548693A patent/JP5554569B2/ja not_active Expired - Fee Related
- 2008-02-08 CN CN201510573883.XA patent/CN105254637A/zh active Pending
- 2008-02-08 US US12/526,553 patent/US8937080B2/en not_active Expired - Fee Related
- 2008-02-08 KR KR1020097015457A patent/KR20090110314A/ko active IP Right Grant
- 2008-02-08 ES ES08708826.6T patent/ES2541660T3/es active Active
- 2008-02-08 CN CN200880003722A patent/CN101641349A/zh active Pending
- 2008-02-08 EP EP08708826.6A patent/EP2118091B1/en not_active Not-in-force
- 2008-02-08 AU AU2008212758A patent/AU2008212758B2/en not_active Ceased
- 2008-02-08 WO PCT/EP2008/051553 patent/WO2008095999A1/en active Application Filing
- 2008-02-08 MX MX2009008540A patent/MX2009008540A/es active IP Right Grant
-
2016
- 2016-07-18 HK HK16108475.9A patent/HK1220455A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP2118091A1 (en) | 2009-11-18 |
CN101641349A (zh) | 2010-02-03 |
HK1220455A1 (zh) | 2017-05-05 |
RU2009133472A (ru) | 2011-03-20 |
ES2541660T3 (es) | 2015-07-23 |
CN105254637A (zh) | 2016-01-20 |
US20100113440A1 (en) | 2010-05-06 |
AU2008212758A1 (en) | 2008-08-14 |
AU2008212758B2 (en) | 2014-01-30 |
US8937080B2 (en) | 2015-01-20 |
KR20090110314A (ko) | 2009-10-21 |
RU2481340C2 (ru) | 2013-05-10 |
JP2010518048A (ja) | 2010-05-27 |
CA2677697A1 (en) | 2008-07-14 |
JP5554569B2 (ja) | 2014-07-23 |
WO2008095999A1 (en) | 2008-08-14 |
EP2118091B1 (en) | 2015-04-15 |
BRPI0807087A2 (pt) | 2014-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009008540A (es) | Inhibidores de virus de hepatitis c macrociclicos sustituidos con pirimidina. | |
MX2009008541A (es) | Fenilcarbamatos macrociclicos que inhiben el virus de hepatitis c. | |
MX2011011136A (es) | Eteres diarilicos. | |
WO2012030685A3 (en) | Indazole derivatives useful as erk inhibitors | |
MX2010003155A (es) | Derivados de ciclopropil aril amida y uso de los mismos. | |
EA200900135A1 (ru) | Производные пиразола в качестве ингибиторов цитохрома р450 | |
SE0400284D0 (sv) | Novel compounds | |
TW200613243A (en) | Novel compounds | |
UA94833C2 (en) | Substituted bicyclolactams | |
WO2007087548A3 (en) | Chemical compounds | |
WO2008005368A3 (en) | Piperazines as p2x7 antagonists | |
MY148634A (en) | Pyridazinone derivatives | |
WO2007117465A3 (en) | Indazole compounds | |
MY174452A (en) | Substituted piperidines that increase p53 activity and the uses thereof | |
WO2007002313A3 (en) | Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants | |
EP1714961A4 (en) | INDAZOL COMPOUND AND THEIR PHARMACEUTICAL USE | |
MY151986A (en) | Adamantyl diamide derivatives and uses of same | |
JO3577B1 (ar) | صيغ صيدلانية تشمل مشتقات 1-(بيتا-d- غلوكوبيرانوسيل) -2-ثينيل ميثيل بنزين كمثبطات sglt | |
WO2007017728A3 (en) | Novel heterocyclic compounds | |
TW200639156A (en) | New compounds | |
TW200806291A (en) | Pharmaceutical formulations | |
PT2049480E (pt) | Derivados de 2-arilindole como inibidores da mpges-i | |
WO2009140341A3 (en) | Atorvastatin compositions | |
MX2009006334A (es) | Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona. | |
TNSN08369A1 (en) | Benzimidazole derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HH | Correction or change in general | ||
FG | Grant or registration |